137 related articles for article (PubMed ID: 10678584)
21. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
Chung J; Chavez PR; Russell RM; Wang XD
Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of JNK is involved in regulation of H(+)-induced c-Jun expression.
Shimokawa N; Qiu CH; Seki T; Dikic I; Koibuchi N
Cell Signal; 2004 Jun; 16(6):723-9. PubMed ID: 15093613
[TBL] [Abstract][Full Text] [Related]
24. Activation of c-Jun NH2-terminal kinase (JNK/SAPK) in LLC-PK1 cells by cadmium.
Matsuoka M; Igisu H
Biochem Biophys Res Commun; 1998 Oct; 251(2):527-32. PubMed ID: 9792807
[TBL] [Abstract][Full Text] [Related]
25. Stress-induced activation of c-Jun N-terminal kinase in sensory ganglion neurons: accumulation in nuclear domains enriched in splicing factors and distribution in perichromatin fibrils.
Pena E; Berciano MT; Fernandez R; Crespo P; Lafarga M
Exp Cell Res; 2000 Apr; 256(1):179-91. PubMed ID: 10739665
[TBL] [Abstract][Full Text] [Related]
26. Pathways for activation of the ras-oncogene-encoded p21 protein.
Pincus MR; Chung D; Dykes DC; Brandt-Rauf P; Weinstein IB; Yamaizumi Z; Nishimura S
Ann Clin Lab Sci; 1992; 22(5):323-42. PubMed ID: 1524403
[TBL] [Abstract][Full Text] [Related]
27. Insulin-induced c-Jun N-terminal kinase activation is negatively regulated by protein kinase C delta.
Morino K; Maegawa H; Fujita T; Takahara N; Egawa K; Kashiwagi A; Kikkawa R
Endocrinology; 2001 Jun; 142(6):2669-76. PubMed ID: 11356718
[TBL] [Abstract][Full Text] [Related]
28. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
[TBL] [Abstract][Full Text] [Related]
29. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.
Leppä S; Bohmann D
Oncogene; 1999 Nov; 18(45):6158-62. PubMed ID: 10557107
[TBL] [Abstract][Full Text] [Related]
30. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
[TBL] [Abstract][Full Text] [Related]
31. 4-Aryl-1,3,2-oxathiazolylium-5-olate: a novel GST inhibitor to release JNK and activate c-Jun for cancer therapy.
Cui H; Shen J; Lu D; Zhang T; Zhang W; Sun D; Wang PG
Cancer Chemother Pharmacol; 2008 Aug; 62(3):509-15. PubMed ID: 18008069
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction.
Chie L; Qu Y; Chung D; Boutjdir M; Pincus MR
J Protein Chem; 2003 Nov; 22(7-8):625-9. PubMed ID: 14714729
[TBL] [Abstract][Full Text] [Related]
33. The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.
Qu Y; Adler V; Izotova L; Pestka S; Bowne W; Michl J; Boutjdir M; Friedman FK; Pincus MR
Front Biosci; 2007 Sep; 12():5089-97. PubMed ID: 17569632
[TBL] [Abstract][Full Text] [Related]
34. Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes.
Qu Y; Adler V; Chu T; Platica O; Michl J; Pestka S; Izotova L; Boutjdir M; Pincus MR
Front Biosci; 2006 Sep; 11():2420-7. PubMed ID: 16720323
[TBL] [Abstract][Full Text] [Related]
35. Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells.
Mischiati C; Pironi F; Milani D; Giacca M; Mirandola P; Capitani S; Zauli G
AIDS; 1999 Sep; 13(13):1637-45. PubMed ID: 10509564
[TBL] [Abstract][Full Text] [Related]
36. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
[TBL] [Abstract][Full Text] [Related]
37. Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation.
Cripe LD; Gelfanov VM; Smith EA; Spigel DR; Phillips CA; Gabig TG; Jung SH; Fyffe J; Hartman AD; Kneebone P; Mercola D; Burgess GS; Boswell HS
Leukemia; 2002 May; 16(5):799-812. PubMed ID: 11986940
[TBL] [Abstract][Full Text] [Related]
38. Complexes of p21RAS with JUN N-terminal kinase and JUN proteins.
Adler V; Pincus MR; Brandt-Rauf PW; Ronai Z
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10585-9. PubMed ID: 7479845
[TBL] [Abstract][Full Text] [Related]
39. Contribution of JNK, Mek, Mos and PI-3K signaling to GVBD in Xenopus oocytes.
Mood K; Bong YS; Lee HS; Ishimura A; Daar IO
Cell Signal; 2004 May; 16(5):631-42. PubMed ID: 14751548
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel phosphorylation site in c-jun directly targeted in vitro by protein kinase D.
Waldron RT; Whitelegge JP; Faull KF; Rozengurt E
Biochem Biophys Res Commun; 2007 May; 356(2):361-7. PubMed ID: 17359934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
